Dow Futures Down Over 400 Points After Disappointing Jobs Data

Stock futures are sharply lower following yesterday's strong monthly gains. The U.S. unemployment rate rose to 4.2% in July, while job growth slowed sharply, with only 73,000 jobs added in comparison to estimates of 100,000. In response, futures on the Dow Jones Industrial Average (DJIA) are off 417 points, while the S&P 500 Index (SPX) and Nasdaq-100 Index (NDX) sit firmly in the red as well.

Modified tariffs from President Donald Trump -- including a 10% hike to Canada's previous 25% levy -- are also weighing on the market, while investors unpack big tech earnings from Amazon.com (AMZN) and Apple (AAPL).

Continue reading for more on today's market, including:

• Caterpillar stock runs higher ahead of quarterly report. 
• Managing earnings season expectations.
• Plus, crypto stock's Q2 blunder; energy giant seeing post-earnings boost; and vaccine maker dragged on dismal sales.

5 Things You Need to Know Today

1. The Cboe Options Exchange (CBOE) saw 2.4 million call contracts and 2 million put contracts traded on Thursday. The single-session equity put/call ratio rose to 0.84, while the 21-day moving average remained at 0.59.
2. Crypto stock Coinbase Global Inc (NASDAQ:COIN) is down 9.2% before the bell, after the company posted a second-quarter revenue and third-quarter outlook miss. COIN has been attempting to recover from a steep fall from its July 18 record peak of $444.64. The 20-day moving average has moved in as resistance, however. Regardless, COIN remains 52% higher in 2025.
3. First Solar Inc (NASDAQ:FSLR) is up 3.4% in premarket trading, after the energy name reported a mixed full-year outlook and second-quarter earnings beat. Should these gains hold, FSLR will snap its four-day losing streak. The equity finished July with a 5.5% gain.
4. Pharma giant Moderna Inc (NASDAQ:MRNA) is off 7% ahead of the open, following the company's smaller-than-anticipated second-quarter loss and 41% drop in year-over-year revenue. The vaccine maker cited lower Covid-19 vaccine sales as a headwind. Over the past 12 months, MRNA has shed a hefty 75%.
5. More earnings are on deck this week.

Asian Markets Plummet as Economic Data Rolls In

Asian markets were coated in red to end the week, with the South Korean Kospi shedding 3.9%, as investors eyed tariff updates stateside. Japan’s Nikkei fell 0.7%, after the country’s unemployment rate stayed unchanged at 2.5% in June. Meanwhile, China’s S&P Global services purchasing managers’ index (PMI) fell to 49.5 in July from 50.4 in June, missing expectations of 50.4 and falling below the 50 mark that separates growth and contraction. China’s Shanghai Composite fell 0.4%, while Hong Kong’s Hang Seng dropped 1.1%.

European bourses are lower as well amid a flood of corporate earnings, with pharmaceutical stocks selling off after U.S. President Trump sent letters across the sector demanding cheaper drug prices. London’s FTSE 100 is down 0.5%, while the French CAC 40 and German DAX are 2.1% and 1.8% lower, respectively.